Treatment of EGFR- or MET-addicted NSCLC cancer cells was shown to cause a metabolic shift toward increased glycolysis and lactate production, which develop chemoresistance in NSCLC cells [66]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.